Indegene Limited (INDGN) Share Analysis
NSE · Healthcare · Healthcare
Indegene Limited (NSE: INDGN) is an Indian listed company in the Healthcare sector and a constituent of NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250. As of 21 Sep 2026, the share price was ₹600.00, market capitalisation ₹14,458 Cr, P/E 34.7, ROE 14.4%.
Get the AI verdict on INDGN: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
Stored fundamentals as of 21 Sep 2026 — not a live quote. Signed-in analysis uses same-day data.
INDGN price and valuation
- Share price
- ₹600.00
- Market cap
- ₹14,458 Cr
- P/E ratio
- 34.7
- P/B ratio
- 4.62
- EPS
- ₹16.66
- Book value per share
- ₹130.00
- Dividend yield
- 0.37%
INDGN profitability and growth
- ROE
- 14.4%
- ROCE
- 18.8%
- Debt to equity
- 0.05
- Revenue growth (3 yr)
- 15%
- Revenue growth (5 yr)
- 29%
- Profit growth (3 yr)
- 16%
- Profit growth (5 yr)
- 23%
INDGN 52-week range
- 52-week high
- ₹615.50
- 52-week low
- ₹414.00
- Face value
- ₹2.00
INDGN shareholding pattern
- Promoters
- -
- FIIs
- 9.92%
- DIIs
- 8.74%
- Public
- 81.34%
Index membership: NIFTY 500, NIFTY MidSmallcap 400, NIFTY Smallcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.